Woodline Partners’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-150,104
Closed -$1.49M 836
2021
Q3
$1.49M Hold
150,104
0.02% 448
2021
Q2
$1.48M Buy
+150,104
New +$1.48M 0.03% 391